Drug
Fluorescein clinical trials
- studies test it
- 19
- open now
- 2
- in phase 3
- 2
- first study started
- 2008
Keep track of what changes. Save the Fluorescein studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 8
- Phase 3
- 2
- Phase 4
- 3
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 17
Aditya Kaza (2) · UpTru Inc. (2) · University of Utah (2) · David W. Roberts (1) · Stanford University (1) · Seoul National University Bundang Hospital (1) · Mayo Clinic (1) · Rennes University Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Fluorescein is read from its arms, and is right about nine times in ten.
Testing it · 19
- Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE Use Disorder (ATTESTED)Not yet recruitingPhase 3UpTru Inc.NCT07356349Written as Fluorescein
- A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)RecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT06873815Written as Fluorescein Sodium
- Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor BiomarkerActive, not recruitingPhase 2David W. RobertsNCT02691923Written as Fluorescein
- Identification of Nerves Using Fluorescein SodiumCompletedPhase 2Stanford UniversityNCT06054178Written as Fluorescein Sodium
- Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical TumorsTerminatedNot applicableUniversity of Colorado, DenverNCT03752203Written as Sodium Fluorescein
- Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)CompletedPhase 4Seoul National University Bundang HospitalNCT05664555Written as Fluorescein Sodium
- Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560CompletedPhase 2Mayo ClinicNCT04351373Written as Fluorescein Sodium
- Optical Tissue Identification for Myocardial ArchitectureActive, not recruitingPhase 2Aditya KazaNCT04017975Written as Fluorescite
- Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the ColonTerminatedNot applicableUniversity of MichiganNCT03220711Written as Fluorescein
- Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)CompletedPhase 3Rennes University HospitalNCT03291977Written as Fluorescéine Sodique Faure
- Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer InvasionCompletedEarly Phase 1University of ArkansasNCT01979003Written as Fluorescein
- Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic HysterectomyCompletedNot applicableCHU de Quebec-Universite LavalNCT02971800Written as sodium fluorescein injection 10%
- Utilization of Confocal Microscopy During Cardiac SurgeryCompletedPhase 1Aditya KazaNCT03189134Written as Fluorescite
- The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine SamplesCompletedPhase 1UpTru Inc.NCT04071080Written as fluorescein sodium
- Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant MelanomaCompletedPhase 1/2University of UtahNCT00847522Written as Fluorescein
- Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial LesionsStatus unknownPhase 4AdventHealthNCT02478346Written as Fluorescein Sodium
- Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial LesionsTerminatedPhase 4Indiana UniversityNCT02028325Written as Fluorescein Sodium
- Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the SkinStatus unknownPhase 2Shandong UniversityNCT02519920Written as fluorescein sodium 0.01ml/kg
- Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast CancerWithdrawnPhase 1/2University of UtahNCT01614184Written as Fluorescein
Codes
What other systems call Fluorescein · ClinicalTrials.gg INT008718
- MeSH (NLM) D019793FluoresceinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) TPY09G7XIRFLUORESCEINConfirmed FDA, NLM, Wikidata
- RxNorm 25138Confirmed FDA, Wikidata
- Wikidata Q410922fluoresceinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61766FluoresceinOne source FDA
- DrugBank DB00693One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019793 | Fluorescein | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | TPY09G7XIR | FLUORESCEIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 25138 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410922 | fluorescein | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61766 | Fluorescein | One source FDA |
| DrugBank | DB00693 | — | One source Wikidata |
Also registered as fluorescein sodium (UNII 93X55PE38X · RxNorm 57789).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.